Focusing on The Association Between Cavum Septum Pellucidum and/or Cavum Vergae and Clinical Symptoms and Drug Therapy in Patients with Schizophrenia.

IF 1.3 Q3 PSYCHIATRY
Alpha psychiatry Pub Date : 2025-04-28 eCollection Date: 2025-04-01 DOI:10.31083/AP40036
Nermin Gündüz, Ahmet Yosmaoğlu, Erkal Erzincan, Gülçin Şenyuva
{"title":"Focusing on The Association Between Cavum Septum Pellucidum and/or Cavum Vergae and Clinical Symptoms and Drug Therapy in Patients with Schizophrenia.","authors":"Nermin Gündüz, Ahmet Yosmaoğlu, Erkal Erzincan, Gülçin Şenyuva","doi":"10.31083/AP40036","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Septum pellucidum is a thin midline brain structure located in the anterior brain, running in a median-sagittal or midsagittal direction. This study aims at testing whether cavum septum pellucidum (CSP) and cavum vergae (CV) could predict clozapine pre- scribing in patients with schizophrenia. This study also assesses the relationship between CSP/CV and some clinical findings in patients with schizophrenia.</p><p><strong>Methods: </strong>190 patients diagnosed with schizophrenia who underwent neuroanatomical evaluation with magnetic resonance imaging during inpatient treatment were included in the study. A personal data form, Positive and Negative Syndrome Scale (PANSS) were given to each patient at admission and discharge. The presence or absence of CSP/CV was recorded as \"yes\" or \"no\".</p><p><strong>Results: </strong>The presence of CSP/CV was found to be associated with the number of hospital admissions, the number of electroconvulsive therapy sessions received, PANSS total score at admission, PANSS total score at discharge and clozapine use. In the logistic regression model created, the presence of CSP and total PANSS score were found to predict clozapine prescribing (respectively <i>p</i> = 0.001, <i>p</i> = 0.016). The Nagelkerke's R<sup>2</sup> value was found to be 0.167.</p><p><strong>Conclusions: </strong>This study holds the distinction of being the first in the field to investigate the relationship between clozapine prescribing and the presence of CSP/CV in schizophrenia patients. There is a need for longitudinal-cohort studies that can better express effect to identify the conditions associated with CSP/CV.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"26 2","pages":"40036"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059739/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alpha psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/AP40036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Septum pellucidum is a thin midline brain structure located in the anterior brain, running in a median-sagittal or midsagittal direction. This study aims at testing whether cavum septum pellucidum (CSP) and cavum vergae (CV) could predict clozapine pre- scribing in patients with schizophrenia. This study also assesses the relationship between CSP/CV and some clinical findings in patients with schizophrenia.

Methods: 190 patients diagnosed with schizophrenia who underwent neuroanatomical evaluation with magnetic resonance imaging during inpatient treatment were included in the study. A personal data form, Positive and Negative Syndrome Scale (PANSS) were given to each patient at admission and discharge. The presence or absence of CSP/CV was recorded as "yes" or "no".

Results: The presence of CSP/CV was found to be associated with the number of hospital admissions, the number of electroconvulsive therapy sessions received, PANSS total score at admission, PANSS total score at discharge and clozapine use. In the logistic regression model created, the presence of CSP and total PANSS score were found to predict clozapine prescribing (respectively p = 0.001, p = 0.016). The Nagelkerke's R2 value was found to be 0.167.

Conclusions: This study holds the distinction of being the first in the field to investigate the relationship between clozapine prescribing and the presence of CSP/CV in schizophrenia patients. There is a need for longitudinal-cohort studies that can better express effect to identify the conditions associated with CSP/CV.

精神分裂症患者透明隔腔和/或空腔与临床症状和药物治疗的关系
目的:透明隔是位于大脑前部的一个薄的脑中线结构,沿正中矢状或正中矢状方向运行。本研究旨在检验透明隔腔(CSP)和vergae腔(CV)是否能预测精神分裂症患者氯氮平的处方。本研究还评估了精神分裂症患者CSP/CV与一些临床表现之间的关系。方法:190例精神分裂症患者在住院治疗期间行核磁共振神经解剖学评价。每位患者在入院和出院时分别获得一份个人资料表,阳性和阴性症状量表(PANSS)。CSP/CV是否存在记录为“是”或“否”。结果:发现CSP/CV的存在与入院次数、接受电休克治疗次数、入院时PANSS总分、出院时PANSS总分和氯氮平使用有关。在建立的logistic回归模型中,发现CSP和PANSS总分的存在预测氯氮平处方(分别p = 0.001, p = 0.016)。Nagelkerke的R2值为0.167。结论:本研究是该领域第一个研究氯氮平处方与精神分裂症患者CSP/CV存在之间关系的研究。有必要进行能够更好地表达疗效的纵向队列研究,以确定与CSP/CV相关的条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信